SpineTop Stories

joimax® Expands Distribution in China

Announces Exclusive Partnership with Andeller (Nanjing) Healthcare and Technology Co., Ltd., a Subsidiary of C&D Corp. Ltd.

July 22, 2022

KARLSRUHE, Germany–(BUSINESS WIRE)–German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, and distributor Andeller (Nanjing) Healthcare and Technology Co., Ltd., a subsidiary of C&D Corp. Ltd., are excited to announce their exclusive partnership for the Chinese market, effective immediately.

Under this new strategic partnership, Andeller will be the sole provider of joimax® products to surgeons and medical practitioners throughout China. The partnership allows the two companies to provide high-quality products and services to the Chinese health community, ensuring that patients have access to the latest endoscopic technologies.

Andeller replaces Shanghai Maoyu Medical Equipment Co. Ltd. Earlier this year, the distribution contract between joimax® and Shanghai Maoyu Medical Equipment Co. Ltd. was terminated due to breach of contract and multiple violations by the Chinese company.

Moreover, the acclaimed joimax® training and education programs will be rolled out to key opinion leaders (KOL), many of whom are longtime joimax® users.

“We are looking forward to working with Andeller, a strong and well-established partner in China,” says joimax® Founder and CEO Wolfgang Ries. “Together, we will continue to provide best-in-class service and education to our community.”

About Andeller (Nanjing) Healthcare and Technology Co., Ltd.

Andeller (Nanjing) Healthcare and Technology Co. Ltd. is a fully owned subsidiary under C&D Corp. Ltd., part of the Fortune Global 500. C&D Corp. Ltd. is a state-owned enterprise with its main business focus on medical services and distribution. With an extended supply chain network and strong capital, C&D Corp. Ltd. distributes medical devices, collaborating with international medical device manufacturers and more than 50% of Class IIIA hospitals.

About joimax®

Founded in Karlsruhe, Germany, in 2001, joimax® is the leading developer and marketer of complete systems for full-endoscopic and minimally invasive spinal surgery. With the Endoscopic Surgical Systems TESSYS® (transforaminal), iLESSYS® (interlaminar) and CESSYS® (cervical) for decompression procedures, MultiZYTE® for facet and sacroiliac joint pain treatment, EndoLIF® and Percusys® for minimally invasive endoscopically assisted stabilizations, established systems are provided, addressing a whole range of indications. In procedures for herniated disc, stenosis, pain therapy or spinal stabilization treatment, surgeons utilize joimax® technologies to operate through small incisions under local or full anesthesia, via tissue and muscle-sparing corridors, and through natural openings in the spinal canal, e.g., the intervertebral foramen, the so-called “Kambin triangle”.

Press Contact Germany
joimax® GmbH
Nicole Read

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button